PEOPLE - Xtent makes appointment:
This article was originally published in Clinica
Drug-eluting stent developer Xtent (Menlo Park, California) has appointed Michael Eagle to its board of directors. Mr Eagle, who has over 30 years experience in the life-sciences industry, was most recently vice-president of manufacturing at Eli Lilly, a post he held for eight years. He is on the board of several companies, including: Favrille (biopharma, chairman); Radiant Medical (endovascular therapeutic cooling); Siegel-Robert (industrial manufacturing); Somaxon Pharmaceutical; and Micrus Endovascular (cerebrovascular implants and disposables).
You may also be interested in...
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.
The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.